Literature DB >> 23311323

Social-cognitive correlates of antiretroviral therapy adherence among HIV-infected individuals receiving infectious disease care in a medium-sized northeastern US city.

Jennifer L Brown1, Rae A Littlewood, Peter A Vanable.   

Abstract

High levels of antiretroviral therapy (ART) adherence are required to achieve optimal viral suppression. To better understand mechanisms associated with ART adherence, this study characterized demographic and social-cognitive correlates of ART adherence among HIV-infected individuals from a medium-sized northeastern US city (n=116; 42% female; 43% African-American). Participants completed an audio computer-assisted self-interviewing survey assessing demographics, social-cognitive constructs, and ART adherence, and the participants' most recent viral load was obtained from their medical charts. Suboptimal ART adherence (taking less than 95% of prescribed medications during the past month) was reported by 39% of participants and was associated with being female, being a minority, and having a detectable viral load. In a hierarchical logistic regression analysis, greater than 95% ART adherence was associated with higher levels of adherence self-efficacy (AOR =1.1; p=0.015), higher perceived normative beliefs about the importance of ART adherence (AOR=1.3; p=0.03), and lower concern about missing ART doses (AOR=0.63; p=0.002). Adherence did not differ based on ART outcome expectancies, ART attitudes, or the perceived necessity of ART. In fact, most participants endorsed positive attitudes and expectancies regarding the need for and effectiveness of ART. Taken together, results indicate that suboptimal adherence remains high among HIV-infected minority women, a subpopulation that experiences particularly high rates of chronic stress due to both illness-specific stressors and broader environmental stressors. Consistent with social-cognitive theory, adherence problems in our sample were linked with deficits in self-efficacy as well as perceived norms and behavioral intentions that do not support a goal of 100% adherence. We suggest that interventions to improve adherence informed by social-cognitive theory (1) target patients who are at risk for adherence problems, (2) provide a supportive environment that promotes high rates of adherence, and (3) address inaccurate beliefs regarding optimal adherence levels.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23311323      PMCID: PMC3626750          DOI: 10.1080/09540121.2012.752566

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  40 in total

1.  A randomized controlled psycho-education intervention trial: Improving psychological readiness for successful HIV medication adherence and reducing depression before initiating HAART.

Authors:  L Balfour; J Kowal; A Silverman; G A Tasca; J B Angel; P A Macpherson; G Garber; C L Cooper; D W Cameron
Journal:  AIDS Care       Date:  2006-10

Review 2.  Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management.

Authors:  Jane M Simoni; Ann E Kurth; Cynthia R Pearson; David W Pantalone; Joseph O Merrill; Pamela A Frick
Journal:  AIDS Behav       Date:  2006-05

3.  An information-motivation-behavioral skills model of adherence to antiretroviral therapy.

Authors:  Jeffrey D Fisher; William A Fisher; K Rivet Amico; Jennifer J Harman
Journal:  Health Psychol       Date:  2006-07       Impact factor: 4.267

4.  A Social Problem-Solving Model of Adherence to HIV Medications.

Authors:  Mallory O Johnson; Timothy R Elliott; Torsten B Neilands; Stephen F Morin; Margaret A Chesney
Journal:  Health Psychol       Date:  2006-05       Impact factor: 4.267

5.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

Authors:  David R Bangsberg
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

6.  Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model.

Authors:  Mallory O Johnson; Margaret A Chesney; Rise B Goldstein; Robert H Remien; Sheryl Catz; Cheryl Gore-Felton; Edwin Charlebois; Stephen F Morin
Journal:  AIDS Patient Care STDS       Date:  2006-04       Impact factor: 5.078

7.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

8.  A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy.

Authors:  Jane M Simoni; Pamela A Frick; Bu Huang
Journal:  Health Psychol       Date:  2006-01       Impact factor: 4.267

9.  Prediction of adherence to antiretroviral therapy: a one-year longitudinal study.

Authors:  G Godin; J Côté; H Naccache; L D Lambert; S Trottier
Journal:  AIDS Care       Date:  2005-05

10.  Factors associated with antiretroviral adherence among HIV-infected women with children.

Authors:  Debra A Murphy; Lisa Greenwell; Dannie Hoffman
Journal:  Women Health       Date:  2002
View more
  18 in total

1.  Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.

Authors:  Sannisha Dale; Mardge Cohen; Kathleen Weber; Ruth Cruise; Gwendolyn Kelso; Leslie Brody
Journal:  AIDS Patient Care STDS       Date:  2014-02-25       Impact factor: 5.078

2.  A Multi-Site Study of Social Cognitive Factors Related to Adherence Among Youth Living With HIV in the New Era of Antiretroviral Medication.

Authors:  Veronica Dinaj-Koci; Bo Wang; Sylvie Naar-King; Karen Kolmodin MacDonell
Journal:  J Pediatr Psychol       Date:  2019-01-01

Review 3.  Necessity and concerns beliefs and HIV medication adherence: a systematic review.

Authors:  Luke D Mitzel; Peter A Vanable
Journal:  J Behav Med       Date:  2019-08-08

4.  Psychometric Evaluation and Predictive Validity of an Adapted Adherence Self-Efficacy Scale for PrEP.

Authors:  Sarit A Golub; Lila Starbuck; Rachel Fikslin; Kristi E Gamarel
Journal:  AIDS Behav       Date:  2022-07-09

5.  Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDS.

Authors:  Linda M Collins; Kari C Kugler; Marya Viorst Gwadz
Journal:  AIDS Behav       Date:  2016-01

6.  Task importance affects event-based prospective memory performance in adults with HIV-associated neurocognitive disorders and HIV-infected young adults with problematic substance use.

Authors:  Steven Paul Woods; Katie L Doyle; Erin E Morgan; Sylvie Naar-King; Angulique Y Outlaw; Sharon L Nichols; Shayne Loft
Journal:  J Int Neuropsychol Soc       Date:  2014-05-16       Impact factor: 2.892

7.  Correlates of Antiretroviral Therapy Adherence among HIV-Infected Older Adults.

Authors:  Katryna McCoy; Drenna Waldrop-Valverde; Benjamin H Balderson; Christine Mahoney; Sheryl Catz
Journal:  J Int Assoc Provid AIDS Care       Date:  2016-04-12

8.  HIV-Related Stigmatization and Medication Adherence: Indirect Effects of Disclosure Concerns and Depression.

Authors:  Luke D Mitzel; Peter A Vanable; Michael P Carey
Journal:  Stigma Health       Date:  2018-05-14

9.  Effects of individual and neighborhood socioeconomic status on antiretroviral therapy adherence: The role of adherence self-efficacy.

Authors:  Yanping Jiang; Xiaoming Li; Hyunsan Cho; Monique J Brown; Shan Qiao; Mohammad R Haider
Journal:  J Health Psychol       Date:  2019-08-16

10.  The importance of domain-specific self-efficacy assessment for substance use and HIV care continuum outcomes among adults in an urban HIV clinic network.

Authors:  Tyrel J Starks; Simone J Skeen; S Scott Jones; Brett M Millar; Sitaji Gurung; Christopher Ferraris; Ana Ventuneac; Jeffrey T Parsons; Martha A Sparks
Journal:  AIDS Care       Date:  2021-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.